The invention relates to novel heteroethynylenic compounds having the general
formula (I):
##STR1##
as well as to the use of these compounds in pharmaceutical compositions intended
for use in human or veterinary medicine (dermatological, rheumatic, respiratory,
cardiovascular and ophthalmological complaints in particular), or alternatively
in cosmetic compositions.
